Source:http://linkedlifedata.com/resource/umls/id/C0014935
MSH: The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy.,NCI: Hormones (estrogen, progesterone, or both) given to postmenopausal women or to women who have had their ovaries surgically removed. Hormones are given to replace the estrogen no longer produced by the ovaries.,NCI: The administration of estrogen, especially in postmenopausal women, to relieve menopausal symptoms and to protect against osteoporosis and heart disease. (Bartleby.com)